Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study.
Yoshino T, Portnoy DC, Obermannová R, Bodoky G, Prausová J, Garcia-Carbonero R, Ciuleanu T, García-Alfonso P, Cohn AL, Van Cutsem E, Yamazaki K, Lonardi S, Muro K, Kim TW, Yamaguchi K, Grothey A, O'Connor J, Taieb J, Wijayawardana SR, Hozak RR, Nasroulah F, Tabernero J. Yoshino T, et al. Ann Oncol. 2019 Jan 1;30(1):124-131. doi: 10.1093/annonc/mdy461. Ann Oncol. 2019. PMID: 30339194 Free PMC article. Clinical Trial.
Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice.
Bekaii-Saab T, Kim R, Kim TW, O'Connor JM, Strickler JH, Malka D, Sartore-Bianchi A, Bi F, Yamaguchi K, Yoshino T, Prager GW. Bekaii-Saab T, et al. Clin Colorectal Cancer. 2019 Mar;18(1):e117-e129. doi: 10.1016/j.clcc.2018.11.002. Epub 2018 Nov 16. Clin Colorectal Cancer. 2019. PMID: 30598357 Free article. Review.
Safety and effectiveness of regorafenib in patients with metastatic colorectal cancer in routine clinical practice in the prospective, observational CORRELATE study.
Ducreux M, Petersen LN, Öhler L, Bergamo F, Metges JP, de Groot JW, Wang JY, García Paredes B, Dochy E, Fiala-Buskies S, Cervantes A, O'Connor JM, Falcone A; CORRELATE Investigators. Ducreux M, et al. Eur J Cancer. 2019 Dec;123:146-154. doi: 10.1016/j.ejca.2019.09.015. Epub 2019 Nov 4. Eur J Cancer. 2019. PMID: 31698328 Free article.
Outcomes of Patients With Metastatic Anal Cancer According to HIV Infection: A Multicenter Study by the Latin American Gastrointestinal Oncology Group (SLAGO).
Mattos BRS, Camandaroba MPG, Ruiz-Garcia E, Diaz-Romero C, Luca R, Mendez G, Lustosa IKF, Silva SF, Mello CA, Silva VS, O'Connor JM, Riechelmann RP. Mattos BRS, et al. Clin Colorectal Cancer. 2021 Dec;20(4):299-304. doi: 10.1016/j.clcc.2021.05.005. Epub 2021 May 24. Clin Colorectal Cancer. 2021. PMID: 34158252
Atypical pattern of response in rectal cancer after neoadjuvant pembrolizumab treatment: a case report, literature review, and proposed management model.
Tissera NS, Esteso F, Luca R, Enrico D, Waisberg F, Rodriguez A, Bruno L, Kucharczyk M, Amat M, García X, Pombo T, Salazar IP, Loria FS, Huertas E, Galli M, Chacón M, O'Connor JM. Tissera NS, et al. J Gastrointest Oncol. 2023 Jun 30;14(3):1635-1642. doi: 10.21037/jgo-22-1140. Epub 2023 Jun 20. J Gastrointest Oncol. 2023. PMID: 37435212 Free PMC article.
Time toxicity of lutetium 177 in gastroenteropancreatic neuroendocrine tumours.
Bortz MD, Rodriguez A, Romina Luca M, Waisberg F, Enrico D, Freile B, Catani G, Esteso F, Musumeci M, Vazquez E, Chacón M, O'Connor JM, Racioppi S. Bortz MD, et al. Among authors: o connor jm. Endocr Oncol. 2024 Nov 20;4(1):e240028. doi: 10.1530/EO-24-0028. eCollection 2024 Jan 1. Endocr Oncol. 2024. PMID: 39649116 Free PMC article.
2,285 results